Press-release for stocks in the health services sector related to positive

Prices are updated after-hours

sector : Health services tags : Positive

save search

Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
Published: 2024-04-05 (Crawled : 12:30) - biospace.com/
NTRA | News S | $88.65 3.95% 3.8% 1.1M

Health Services

| -4.37% | O: 2.12% H: 4.35% C: 2.25%
bladder positive cancer trial

Fresenius Medical Care enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million - 2023 earnings outlook raised
Published: 2023-11-21 (Crawled : 21:00) - prnewswire.com
FMCQF | $42.034 -0.37% 750

Health Services

| Email alert Add to watchlist
favorable positive care impact medical agreement

Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
Published: 2023-09-26 (Crawled : 20:00) - prnewswire.com
CRDF | $4.34 -0.23% -0.23% 460K

Health Services

| 169.14% | O: 17.9% H: 4.97% C: -16.23%
lung positive onvansertib cancer pancreatic cell

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for Pegunigalsidase Alfa for Treatment of Fabry Disease
Published: 2023-02-24 (Crawled : 21:00) - biospace.com/
PLX | $1.18 2.61% 0.0% 230K

Health Services

| -30.59% | O: 0.59% H: 15.2% C: 6.43%
treatment rare global disease chmp positive

SmileDirectClub Announces Plan to Drive Profitability, Positive Cash Flow
Published: 2023-01-17 (Crawled : 22:00) - globenewswire.com
SDC | $0.075 -13.33% 66M

Health Services

| -87.39% | O: 9.26% H: 6.14% C: -13.86%
flow positive

OncoSec Announces Positive Clinical Data of the KEYNOTE-695 Trial Assessing TAVO-EP in Combination with Pembrolizumab (Keytruda®) in Patients with Advanced Melanoma Refractory to anti-PD-1 Treatment
Published: 2022-11-11 (Crawled : 14:00) - biospace.com/
ONCS | $0.2772 25.59% 52M

Health Services

| -94.06% | O: 3.85% H: 0.0% C: 0.0%
ynote-695 keytruda treatment melanoma trial positive

Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow and Realize Full Potential of Industry-Leading Genetics Testing Platform
Published: 2022-07-18 (Crawled : 00:00) - biospace.com/
NVTA | News | $0.019 0.0% 22M

Health Services

| -99.33% | O: 3.16% H: 3.74% C: -9.18%
flow potential positive platform

Optinose Announces Additional Positive Results from ReOpen2 and Initial Results from Pooled Analyses of Both Trials in the ReOpen Program
Published: 2022-07-08 (Crawled : 16:00) - globenewswire.com
OPTN | $0.9644 7.85% 7.28% 1.2M

Health Services

| -73.86% | O: -1.02% H: 2.56% C: -1.54%
trials program positive results

Optinose Announces Positive Top-line Results of ReOpen2, its second Phase 3 Clinical Trial of XHANCE for Treatment of Chronic Sinusitis
Published: 2022-06-13 (Crawled : 12:20) - biospace.com/
OPTN | $0.9644 7.85% 7.28% 1.2M

Health Services

| -43.72% | O: 17.49% H: 31.63% C: 21.4%
treatment trial positive topline phase 3

ObsEva Announces Confirmation of Positive CHMP Opinion for Linzagolix, an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids
Published: 2022-04-25 (Crawled : 06:00) - globenewswire.com
SYNH | $42.98 0.0% 7.4M

Health Services

| -45.48% | O: -8.39% H: 1.73% C: 0.48%
OBSV | $0.1018 -15.52% -18.95% 8.2M

Health Technology

| -92.73% | O: 4.29% H: 9.59% C: 8.22%
treatment chmp positive

Workforce Drug Test Positivity Climbs to Highest Level in Two Decades, Finds Quest Diagnostics Drug Testing Index Analysis
Published: 2022-03-30 (Crawled : 12:20) - prnewswire.com
DGX | News | $130.09 1.29% 0.0% 1.7M

Health Services

| -7.99% | O: -0.06% H: 0.18% C: -1.66%
drug diagnostics test index positive diagnostic

Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis
Published: 2022-03-07 (Crawled : 13:30) - biospace.com/
OPTN | $0.9644 7.85% 7.28% 1.2M

Health Services

| -63.6% | O: -3.89% H: 0.0% C: 0.0%
pos trial report positive results phase 3 topline

Natera Announces Results of Large, Multi-Center Clinical Experience Study Showing Excellent Positive Predictive Value of the Prospera™ Kidney Test
Published: 2022-02-17 (Crawled : 14:00) - biospace.com/
NTRA | News S | $88.65 3.95% 3.8% 1.1M

Health Services

| 23.93% | O: -1.52% H: 0.84% C: -6.69%
kidney cel test positive results

NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR(TM) in Head and Neck Squamous Cell Carcinoma
Published: 2022-02-11 (Crawled : 08:00) - biospace.com/
NEO | $13.43 -0.74% -0.74% 800K

Health Services

| -41.66% | O: -1.5% H: 0.0% C: 0.0%
genomics genomic cel positive results positive results head and neck cell carcinoma

Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR™ in Head and Neck Squamous Cell Carcinoma
Published: 2022-02-11 (Crawled : 08:00) - biospace.com/
NEO | $13.43 -0.74% -0.74% 800K

Health Services

| -41.66% | O: -1.5% H: 0.0% C: 0.0%
cel positive results positive results head and neck cell carcinoma

Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver™ for Early Liver Cancer Detection
Published: 2021-11-08 (Crawled : 16:00) - biospace.com/
FLGT | $20.59 1.13% 1.12% 160K

Health Services

| -73.4% | O: 0.48% H: 4.47% C: 3.45%
genetic positive cancer liver

SomaLogic expands leadership team with new positions to drive commercial success
Published: 2021-08-31 (Crawled : 21:00) - globenewswire.com
NTRA | News S | $88.65 3.95% 3.8% 1.1M

Health Services